CAR T therapy has shown significant efficacy in treating certain types of blood cancers, such as relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL). Research is ongoing to expand its application to other types of cancers, including solid tumors such as glioblastoma and pancreatic cancer.
